Neoplasia/BPH

	Role of APOC1 and NOP16 in the diagnosis of prostate cancer. BMC Urol Yan Y, Shuang S, Fan Z, Wei Z, Li B, Yuan Q, Lu Y, Ye C, Lu P. PMID: 41408238 [PubMed - as supplied by publisher]
	Preclinical evaluation of (68)Ga- and (177)Lu-Labeled AP-01 for the targeted treatment of prostate cancer with moderate PSMA expression. Eur J Nucl Med Mol Imaging Liu Y, Wang X, Pan X, Huang X, He S, Zhang J, Xu X, Song S. PMID: 41407974 [PubMed - as supplied by publisher]
	A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024. Eur J Cancer Vogl UM, Merler S, Angrisani A, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small EJ, Smith MR, Sweeney CJ, Tombal B, Zilli T, Herrmann K, Omlin A, Gillessen S, APCCC 2024 expert panel. PMID: 41407614 [PubMed - as supplied by publisher]
	Re: European Study of Prostate Cancer Screening - 23-Year Follow-up. Eur Urol Nguyen DD, Kulkarni GS, Guyatt GH. PMID: 41407562 [PubMed - as supplied by publisher]
	Re: Niraparib and Abiraterone Acetate plus Prednisone for HRR-deficient Metastatic Castration-sensitive Prostate Cancer: A Randomized Phase 3 Trial. Eur Urol McKenzie J, Azad AA. PMID: 41407561 [PubMed - as supplied by publisher]
	Letter to the Editor: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone sensitive prostate cancer: CAPItello-281 phase III study. Ann Oncol Turco F, Vogl UM, Lin HM, Pedrani M, Leone G, Gillessen S. PMID: 41407194 [PubMed - as supplied by publisher]
	Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer. Pathol Res Pract Cui H, Fan X. PMID: 41406921 [PubMed - as supplied by publisher]
	Association between kidney stones and future risk of kidney cancer: A systematic review and meta-analysis. Can Urol Assoc J Bhojani N, Miller LE, Bhattacharyya S, Chen KW, Kallidonis P, Contreras PS, Somani BK, Gauhar V, Chew BH. PMID: 41406348 [PubMed - as supplied by publisher]
	Lactate metabolism orchestrates immune dysregulation in renal cancer: A multi-omics and causal inference study. Sci Prog Li J, Liu C, Fu Z, He Q, Liu X, Sun Z. PMID: 41406083 [PubMed - indexed for MEDLINE]
	Multi-omics data integration for enhanced cancer subtyping via interactive multi-kernel learning. Brief Bioinform Cao H, Wang T, Xu Z, Zhao X, Liu G, Yang X, Fang R, Luo Y, Zeng P, Yu H, Zhang Y, Cui Y. PMID: 41405963 [PubMed - indexed for MEDLINE]
	From Radiomics to Radiogenomics: Decoding Renal Cell Carcinoma Biology for Precision Medicine-a narrative review. Insights Imaging He Z, Huang L. PMID: 41405787 [PubMed]
	Management of NOACs in patients undergoing water vapour thermal therapy (REZUM) for benign prostatic obstruction: a comprehensive review. World J Urol Coscarella M, Secco S, Elterman DS, Baboudjian M, Al Barajraji M, Leclercq M, Gillard F, Moussa I, Pedini M, Holz S, Dalati F, Fourmarier M, Roumeguère T, Cindolo L. PMID: 41405700 [PubMed - indexed for MEDLINE]
	Thoracic residual germ cell tumor resection after high-dose chemotherapy with autologous stem cell transplantation in relapsed patients. World J Urol Sponholz S, Karaindros G, Ntelli KC, Schirren M, Albers P, Che Y, Lorch A, Walles T, Fisseler-Eckhoff A, Schirren J. PMID: 41405695 [PubMed - indexed for MEDLINE]
	A commentary on "Abbreviated biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in treatment-naÃ¯ve patients: a diagnostic test accuracy systematic review and meta-analysis". Int J Surg Tang W, Wang Y, Zhang Y. PMID: 41405335 [PubMed - as supplied by publisher]
	Clinical trial landscape of cellular therapies in bladder cancer. Int J Surg Zhang Y, Lv S, Li Z, Wang X, Zhu Y. PMID: 41405333 [PubMed - as supplied by publisher]
	Evaluating Molecular and Immune Biomarkers in Predicting Bladder Cancer Recurrence and Survival: A Systematic Review. Cureus Masood S, Shaikh A, Brar Y. PMID: 41404236 [PubMed]
	Renal Medullary Carcinoma: A Call for Screening and Early Diagnosis. Cureus Ponnam HC, Shirsat P, Parsi S, Ravi U, Sonavane K, Ravakhah K. PMID: 41404216 [PubMed]
	The S100 protein family in bladder cancer: mechanisms, clinical value, and targeted therapeutic prospects. Front Oncol Zhang L, Yang G, Huang L, Deng A, Ao M, Li J. PMID: 41404073 [PubMed]
	Case Report: High-volume, aggressive prostate cancer with borderline psa levels diagnosed by PSMA PET/CT-based comprehensive radiographic scheme and cognitive fusion targeted biopsy. Front Oncol Zhou Y, Qiu R, Dou M, Bi W, Yu Y. PMID: 41404062 [PubMed]
	Clinicohistopathological characteristics of renal cell carcinoma in Jordan. Future Sci OA Al-Zubi M, Haddad R, Badr A, Al Bibi H, Azzam S, Araydah M, Al Sharie A, Khattab K, Qasim H, Al Sharie S. PMID: 41403303 [PubMed]

Articles 1 - 20 / 184048

Page 1 of 9203



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy